VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q60329463  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000134.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q60329463‏
024 ‎‡a  0000-0002-5642-1379‏ ‎‡2  orcid‏
024 ‎‡a  35468222700‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q60329463‏
100 0 ‎‡a  Jean S Marshall‏ ‎‡9  sq‏ ‎‡9  ast‏
375 ‎‡a  2‏ ‎‡2  iso5218‏
400 0 ‎‡a  জিন এস মার্শাল‏ ‎‡9  bn‏
400 0 ‎‡a  Jean S Marshall‏ ‎‡c  Canadian immunologist‏ ‎‡9  en‏
400 0 ‎‡a  Jean S Marshall‏ ‎‡c  onderzoeker‏ ‎‡9  nl‏
670 ‎‡a  Author's A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth.‏
670 ‎‡a  Author's A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release.‏
670 ‎‡a  Author's A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines.‏
670 ‎‡a  Author's Aging in the absence of TLR2 is associated with reduced IFN-gamma responses in the large intestine and increased severity of induced colitis‏
670 ‎‡a  Author's An introduction to immunology and immunopathology‏
670 ‎‡a  Author's Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells.‏
670 ‎‡a  Author's Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.‏
670 ‎‡a  Author's CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection‏
670 ‎‡a  Author's Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.‏
670 ‎‡a  Author's Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation‏
670 ‎‡a  Author's Cytokines and Soluble Receptors in Breast Milk as Enhancers of Oral Tolerance Development‏
670 ‎‡a  Author's Dengue virus infection of mast cells triggers endothelial cell activation.‏
670 ‎‡a  Author's Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori‏
670 ‎‡a  Author's Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells.‏
670 ‎‡a  Author's Enhancement of mast cell IL-6 production by combined toll-like and nucleotide-binding oligomerization domain-like receptor activation‏
670 ‎‡a  Author's Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism.‏
670 ‎‡a  Author's Histamine does not mediate mucosal permeability changes after subclinical intestinal ischemia-reperfusion injury‏
670 ‎‡a  Author's Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism.‏
670 ‎‡a  Author's IgE-mediated mast cell activation induces Langerhans cell migration in vivo.‏
670 ‎‡a  Author's IL-4 enhances interferon production by virus-infected human mast cells‏
670 ‎‡a  Author's IL-7Rα and L-selectin, but not CD103 or CD34, are required for murine peanut-induced anaphylaxis.‏
670 ‎‡a  Author's Interferon α2 and interferon γ induce the degranulation independent production of VEGF-A and IL-1 receptor antagonist and other mediators from human mast cells‏
670 ‎‡a  Author's Keystone symposium on 'Mast cells, Basophils and IgE: host defense and disease'‏
670 ‎‡a  Author's Local and systemic immunological parameters associated with remission of asthma symptoms in children.‏
670 ‎‡a  Author's MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer.‏
670 ‎‡a  Author's Mast-cell responses to pathogens.‏
670 ‎‡a  Author's Mast Cell Responses to Viruses and Pathogen Products‏
670 ‎‡a  Author's Mast cells and IgE activation do not alter the development of oral tolerance in a murine model.‏
670 ‎‡a  Author's Mast Cells and Natural Killer Cells-A Potentially Critical Interaction‏
670 ‎‡a  Author's Mast cells and the nerves--potential interactions in the context of chronic disease.‏
670 ‎‡a  Author's Mast cells as targets for immunotherapy of solid tumors.‏
670 ‎‡a  Author's Mast Cells Have a Pivotal Role in TNF-Independent Lymph Node Hypertrophy and the Mobilization of Langerhans Cells in Response to Bacterial Peptidoglycan‏
670 ‎‡a  Author's Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention‏
670 ‎‡a  Author's Mast cells in innate immunity‏
670 ‎‡a  Author's Modulation of rat uterine contractility by mast cells and their mediators‏
670 ‎‡a  Author's Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells.‏
670 ‎‡a  Author's Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism.‏
670 ‎‡a  Author's Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response‏
670 ‎‡a  Author's Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.‏
670 ‎‡a  Author's Recovery free of heart failure after acute coronary syndrome and coronary revascularization.‏
670 ‎‡a  Author's Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line‏
670 ‎‡a  Author's Repeated antigen challenge in rats induces a mucosal mast cell hyperplasia‏
670 ‎‡a  Author's Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4.‏
670 ‎‡a  Author's RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection.‏
670 ‎‡a  Author's SDF-1 induces IL-8 production and transendothelial migration of human cord blood-derived mast cells‏
670 ‎‡a  Author's Selective antibody blockade of lymphocyte migration to mucosal sites and mast cell adhesion‏
670 ‎‡a  Author's Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa‏
670 ‎‡a  Author's Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice‏
670 ‎‡a  Author's Stress triggered abortions are associated with alterations of granulated cells into the decidua.‏
670 ‎‡a  Author's The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice.‏
670 ‎‡a  Author's The gut microbiota of toll-like receptor 2-deficient mice exhibits lineage-specific modifications.‏
670 ‎‡a  Author's The impact of ranitidine on monocyte responses in the context of solid tumors.‏
670 ‎‡a  Author's The role of mast cells in inflammatory reactions of the airways, skin and intestine.‏
670 ‎‡a  Author's Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells.‏
670 ‎‡a  Author's Toll-like receptor 2 activators modulate oral tolerance in mice.‏
670 ‎‡a  Author's Toll-like receptor 2 as a regulator of oral tolerance in the gastrointestinal tract.‏
670 ‎‡a  Author's Toll-like receptor 2 impacts the development of oral tolerance in mouse pups via a milk-dependent mechanism‏
670 ‎‡a  Author's Toll-Like Receptor-Mediated Activation of Mast Cells: Implications for Allergic Disease?‏
670 ‎‡a  Author's VEGF-A is increased in exogenous endophthalmitis.‏
670 ‎‡a  Author's Virus-Infected Human Mast Cells Enhance Natural Killer Cell Functions.‏
670 ‎‡a  Author's Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands.‏
670 ‎‡a  Author's Zebrafish mast cells possess an FcɛRI-like receptor and participate in innate and adaptive immune responses.‏
670 ‎‡a  Author's Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species‏
670 ‎‡a  Author's Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation.‏
670 ‎‡a  wikidata site links‏ ‎‡u  https://en.wikipedia.org/wiki/Jean_Marshall‏
909 ‎‡a  (orcid) 0000000256421379‏ ‎‡9  1‏
909 ‎‡a  (scopus) 35468222700‏ ‎‡9  1‏
919 ‎‡a  cuttingedgedistincttolllikereceptor2activatorsselectivelyinducedifferentclassesofmediatorproductionfromhumanmastcells‏ ‎‡A  Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.‏ ‎‡9  1‏
919 ‎‡a  cytokineandeosinophilresponsesinthelungperipheralbloodandbonemarrowcompartmentsinamurinemodelofallergeninducedairwaysinflammation‏ ‎‡A  Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation‏ ‎‡9  1‏
919 ‎‡a  cytokinesandsolublereceptorsinbreastmilkasenhancersoforaltolerancedevelopment‏ ‎‡A  Cytokines and Soluble Receptors in Breast Milk as Enhancers of Oral Tolerance Development‏ ‎‡9  1‏
919 ‎‡a  denguevirusinfectionofmastcellstriggersendothelialcellactivation‏ ‎‡A  Dengue virus infection of mast cells triggers endothelial cell activation.‏ ‎‡9  1‏
919 ‎‡a  virusinfectedhumanmastcellsenhancenaturalkillercellfunctions‏ ‎‡A  Virus-Infected Human Mast Cells Enhance Natural Killer Cell Functions.‏ ‎‡9  1‏
919 ‎‡a  vegfaisincreasedinexogenousendophthalmitis‏ ‎‡A  VEGF-A is increased in exogenous endophthalmitis.‏ ‎‡9  1‏
919 ‎‡a  tolllikereceptormediatedactivationofmastcellsimplicationsforallergicdisease‏ ‎‡A  Toll-Like Receptor-Mediated Activation of Mast Cells: Implications for Allergic Disease?‏ ‎‡9  1‏
919 ‎‡a  tolllikereceptor2impactsthedevelopmentoforaltoleranceinmousepupsviaamilkdependentmechanism‏ ‎‡A  Toll-like receptor 2 impacts the development of oral tolerance in mouse pups via a milk-dependent mechanism‏ ‎‡9  1‏
919 ‎‡a  tolllikereceptor2asaregulatoroforaltoleranceinthegastrointestinaltract‏ ‎‡A  Toll-like receptor 2 as a regulator of oral tolerance in the gastrointestinal tract.‏ ‎‡9  1‏
919 ‎‡a  tolllikereceptor2activatorsmodulateoraltoleranceinmice‏ ‎‡A  Toll-like receptor 2 activators modulate oral tolerance in mice.‏ ‎‡9  1‏
919 ‎‡a  tissueeosinophiliainamousemodelofcolitisishighlydependentontlr2andindependentofmastcells‏ ‎‡A  Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells.‏ ‎‡9  1‏
919 ‎‡a  roleofmastcellsininflammatoryreactionsoftheairwaysskinandintestine‏ ‎‡A  The role of mast cells in inflammatory reactions of the airways, skin and intestine.‏ ‎‡9  1‏
919 ‎‡a  impactofranitidineonmonocyteresponsesinthecontextofsolidtumors‏ ‎‡A  The impact of ranitidine on monocyte responses in the context of solid tumors.‏ ‎‡9  1‏
919 ‎‡a  gutmicrobiotaoftolllikereceptor2deficientmiceexhibitslineagespecificmodifications‏ ‎‡A  The gut microbiota of toll-like receptor 2-deficient mice exhibits lineage-specific modifications.‏ ‎‡9  1‏
919 ‎‡a  developmentofearlyhostresponsetopseudomonasaeruginosalunginfectioniscriticallydependentonmyeloiddifferentiationfactor88inmice‏ ‎‡A  The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice.‏ ‎‡9  1‏
919 ‎‡a  stresstriggeredabortionsareassociatedwithalterationsofgranulatedcellsintothedecidua‏ ‎‡A  Stress triggered abortions are associated with alterations of granulated cells into the decidua.‏ ‎‡9  1‏
919 ‎‡a  signaltransducerandactivatoroftranscription4stat4butnotil12contributestopseudomonasaeruginosainducedlunginflammationinmice‏ ‎‡A  Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice‏ ‎‡9  1‏
919 ‎‡a  selectiveearlyproductionofccl20ormacrophageinflammatoryprotein3alphabyhumanmastcellsinresponsetopseudomonasaeruginosa‏ ‎‡A  Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa‏ ‎‡9  1‏
919 ‎‡a  selectiveantibodyblockadeoflymphocytemigrationtomucosalsitesandmastcelladhesion‏ ‎‡A  Selective antibody blockade of lymphocyte migration to mucosal sites and mast cell adhesion‏ ‎‡9  1‏
919 ‎‡a  sdf1inducesil8productionandtransendothelialmigrationofhumancordbloodderivedmastcells‏ ‎‡A  SDF-1 induces IL-8 production and transendothelial migration of human cord blood-derived mast cells‏ ‎‡9  1‏
919 ‎‡a  rnasensorsenablehumanmastcellantiviralchemokineproductionandifnmediatedprotectioninresponsetoantibodyenhanceddenguevirusinfection‏ ‎‡A  RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection.‏ ‎‡9  1‏
919 ‎‡a  respiratorysyncytialvirusinfectionofprimaryhumanmastcellsinducestheselectiveproductionoftype1interferonscxcl10andccl4‏ ‎‡A  Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4.‏ ‎‡9  1‏
919 ‎‡a  repeatedantigenchallengeinratsinducesamucosalmastcellhyperplasia‏ ‎‡A  Repeated antigen challenge in rats induces a mucosal mast cell hyperplasia‏ ‎‡9  1‏
919 ‎‡a  releaseofvasoactivecytokinesbyantibodyenhanceddenguevirusinfectionofahumanmastcellbasophilline‏ ‎‡A  Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line‏ ‎‡9  1‏
919 ‎‡a  recoveryfreeofheartfailureafteracutecoronarysyndromeandcoronaryrevascularization‏ ‎‡A  Recovery free of heart failure after acute coronary syndrome and coronary revascularization.‏ ‎‡9  1‏
919 ‎‡a  ranitidinemodifiesmyeloidcellpopulationsandinhibitsbreasttumordevelopmentandspreadinmice‏ ‎‡A  Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.‏ ‎‡9  1‏
919 ‎‡a  ranitidineinhibitionofbreasttumorgrowthisbcelldependentandassociatedwithanenhancedantitumorantibodyresponse‏ ‎‡A  Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response‏ ‎‡9  1‏
919 ‎‡a  prostaglandine2selectivelyenhancestheigemediatedproductionofil6andgranulocytemacrophagecolonystimulatingfactorbymastcellsthroughanep1ep3dependentmechanism‏ ‎‡A  Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism.‏ ‎‡9  1‏
919 ‎‡a  prostaglandine2inducesdegranulationindependentproductionofvascularendothelialgrowthfactorbyhumanmastcells‏ ‎‡A  Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells.‏ ‎‡9  1‏
919 ‎‡a  modulationofratuterinecontractilitybymastcellsandtheirmediators‏ ‎‡A  Modulation of rat uterine contractility by mast cells and their mediators‏ ‎‡9  1‏
919 ‎‡a  mastcellsininnateimmunity‏ ‎‡A  Mast cells in innate immunity‏ ‎‡9  1‏
919 ‎‡a  mastcellsincardiacfibrosisnewinsightssuggestopportunitiesforintervention‏ ‎‡A  Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention‏ ‎‡9  1‏
919 ‎‡a  mastcellshaveapivotalroleintnfindependentlymphnodehypertrophyandthemobilizationoflangerhanscellsinresponsetobacterialpeptidoglycan‏ ‎‡A  Mast Cells Have a Pivotal Role in TNF-Independent Lymph Node Hypertrophy and the Mobilization of Langerhans Cells in Response to Bacterial Peptidoglycan‏ ‎‡9  1‏
919 ‎‡a  mastcellsastargetsforimmunotherapyofsolidtumors‏ ‎‡A  Mast cells as targets for immunotherapy of solid tumors.‏ ‎‡9  1‏
919 ‎‡a  mastcellsandthenervespotentialinteractionsinthecontextofchronicdisease‏ ‎‡A  Mast cells and the nerves--potential interactions in the context of chronic disease.‏ ‎‡9  1‏
919 ‎‡a  mastcellsandnaturalkillercellsapotentiallycriticalinteraction‏ ‎‡A  Mast Cells and Natural Killer Cells-A Potentially Critical Interaction‏ ‎‡9  1‏
919 ‎‡a  mastcellsandigeactivationdonotalterthedevelopmentoforaltoleranceinamurinemodel‏ ‎‡A  Mast cells and IgE activation do not alter the development of oral tolerance in a murine model.‏ ‎‡9  1‏
919 ‎‡a  mastcellresponsestovirusesandpathogenproducts‏ ‎‡A  Mast Cell Responses to Viruses and Pathogen Products‏ ‎‡9  1‏
919 ‎‡a  mastcellresponsestopathogens‏ ‎‡A  Mast-cell responses to pathogens.‏ ‎‡9  1‏
919 ‎‡a  mapkkinase3isatumorsuppressorwithreducedcopynumberinbreastcancer‏ ‎‡A  MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer.‏ ‎‡9  1‏
919 ‎‡a  localandsystemicimmunologicalparametersassociatedwithremissionofasthmasymptomsinchildren‏ ‎‡A  Local and systemic immunological parameters associated with remission of asthma symptoms in children.‏ ‎‡9  1‏
919 ‎‡a  keystonesymposiumonmastcellsbasophilsandigehostdefenseanddisease‏ ‎‡A  Keystone symposium on 'Mast cells, Basophils and IgE: host defense and disease'‏ ‎‡9  1‏
919 ‎‡a  interferonα2andinterferonγinducethedegranulationindependentproductionofvegfaandil1receptorantagonistandothermediatorsfromhumanmastcells‏ ‎‡A  Interferon α2 and interferon γ induce the degranulation independent production of VEGF-A and IL-1 receptor antagonist and other mediators from human mast cells‏ ‎‡9  1‏
919 ‎‡a  7rαand50selectinbutnotcd103orcd34arerequiredformurinepeanutinducedanaphylaxis‏ ‎‡A  IL-7Rα and L-selectin, but not CD103 or CD34, are required for murine peanut-induced anaphylaxis.‏ ‎‡9  1‏
919 ‎‡a  zebrafishmastcellspossessanfcɛrilikereceptorandparticipateininnateandadaptiveimmuneresponses‏ ‎‡A  Zebrafish mast cells possess an FcɛRI-like receptor and participate in innate and adaptive immune responses.‏ ‎‡9  1‏
919 ‎‡a  zymosantreatmentofmousemastcellsenhancesdectin1expressionandinducesdectin1dependentreactiveoxygenspecies‏ ‎‡A  Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species‏ ‎‡9  1‏
919 ‎‡a  zymosantreatmentofmousemastcellsenhancesdectin1expressionandinducesdectin1dependentreactiveoxygenspeciesrosgeneration‏ ‎‡A  Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation.‏ ‎‡9  1‏
919 ‎‡a  4enhancesinterferonproductionbyvirusinfectedhumanmastcells‏ ‎‡A  IL-4 enhances interferon production by virus-infected human mast cells‏ ‎‡9  1‏
919 ‎‡a  igemediatedmastcellactivationinduceslangerhanscellmigrationinvivo‏ ‎‡A  IgE-mediated mast cell activation induces Langerhans cell migration in vivo.‏ ‎‡9  1‏
919 ‎‡a  humanmastcellactivationwithvirusassociatedstimulileadstotheselectivechemotaxisofnaturalkillercellsbyacxcl8dependentmechanism‏ ‎‡A  Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism.‏ ‎‡9  1‏
919 ‎‡a  histaminedoesnotmediatemucosalpermeabilitychangesaftersubclinicalintestinalischemiareperfusioninjury‏ ‎‡A  Histamine does not mediate mucosal permeability changes after subclinical intestinal ischemia-reperfusion injury‏ ‎‡9  1‏
919 ‎‡a  fungalzymosaninducesleukotrieneproductionbyhumanmastcellsthroughadectin1dependentmechanism‏ ‎‡A  Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism.‏ ‎‡9  1‏
919 ‎‡a  enhancementofmastcellil6productionbycombinedtolllikeandnucleotidebindingoligomerizationdomainlikereceptoractivation‏ ‎‡A  Enhancement of mast cell IL-6 production by combined toll-like and nucleotide-binding oligomerization domain-like receptor activation‏ ‎‡9  1‏
919 ‎‡a  dramaticcaspasedependentapoptosisinantibodyenhanceddenguevirusinfectionofhumanmastcells‏ ‎‡A  Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells.‏ ‎‡9  1‏
919 ‎‡a  developmentofaninterleukin12deficientmousemodelthatispermissiveforcolonizationbyamotileke26695strainofhelicobacterpylori‏ ‎‡A  Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori‏ ‎‡9  1‏
919 ‎‡a  virusstimulationofhumanmastcellsresultsintherecruitmentofcd56+tcellsbyamechanismdependentonccr5ligands‏ ‎‡A  Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands.‏ ‎‡9  1‏
919 ‎‡a  criticalroleformastcellsandmastcellderivedil6intlr2mediatedinhibitionoftumorgrowth‏ ‎‡A  A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth.‏ ‎‡9  1‏
919 ‎‡a  dominantroleforfcgammariiinantibodyenhanceddenguevirusinfectionofhumanmastcellsandassociatedccl5release‏ ‎‡A  A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release.‏ ‎‡9  1‏
919 ‎‡a  th1inducingadjuvantmplenhancesantibodyprofilesinexperimentalanimalssuggestingithasthepotentialtoimprovetheefficacyofallergyvaccines‏ ‎‡A  A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines.‏ ‎‡9  1‏
919 ‎‡a  agingintheabsenceoftlr2isassociatedwithreducedifngammaresponsesinthelargeintestineandincreasedseverityofinducedcolitis‏ ‎‡A  Aging in the absence of TLR2 is associated with reduced IFN-gamma responses in the large intestine and increased severity of induced colitis‏ ‎‡9  1‏
919 ‎‡a  introductiontoimmunologyandimmunopathology‏ ‎‡A  An introduction to immunology and immunopathology‏ ‎‡9  1‏
919 ‎‡a  autophagyfacilitatesantibodyenhanceddenguevirusinfectioninhumanprebasophilmastcells‏ ‎‡A  Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells.‏ ‎‡9  1‏
919 ‎‡a  bovinelactoferricininhibitsbasicfibroblastgrowthfactorandvascularendothelialgrowthfactor165inducedangiogenesisbycompetingforheparinlikebindingsitesonendothelialcells‏ ‎‡A  Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.‏ ‎‡9  1‏
919 ‎‡a  cd43butnotcd43+il10producingcd1dhicd5+bcellssuppresstype1immuneresponsesduringchlamydiamuridarumgenitaltractinfection‏ ‎‡A  CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection‏ ‎‡9  1‏
946 ‎‡a  a‏ ‎‡9  1‏
996 ‎‡2  BIBSYS|2131252‏
996 ‎‡2  NTA|067798306‏
996 ‎‡2  ISNI|0000000511408199‏
996 ‎‡2  LC|nb2003104313‏
996 ‎‡2  NII|DA04074031‏
996 ‎‡2  NII|DA07666660‏
996 ‎‡2  N6I|vtls001354742‏
996 ‎‡2  NSK|000391586‏
996 ‎‡2  LC|nb2013021563‏
996 ‎‡2  ISNI|0000000050020721‏
996 ‎‡2  ISNI|0000000047902010‏
996 ‎‡2  LC|n 95041921‏
996 ‎‡2  N6I|vtls000074642‏
996 ‎‡2  NTA|43827203X‏
996 ‎‡2  BIBSYS|2007683‏
996 ‎‡2  CAOONL|ncf10016299‏
996 ‎‡2  DNB|1264246528‏
996 ‎‡2  LC|n 88619943‏
996 ‎‡2  LC|n 50041487‏
996 ‎‡2  ISNI|0000000451621026‏
996 ‎‡2  SUDOC|266960359‏
996 ‎‡2  BLBNB|000173192‏
996 ‎‡2  ISNI|000000004230664X‏
996 ‎‡2  ISNI|0000000031428852‏
996 ‎‡2  BIBSYS|90834858‏
996 ‎‡2  ISNI|0000000049183304‏
996 ‎‡2  PTBNP|838321‏
996 ‎‡2  ISNI|0000000067661939‏
996 ‎‡2  LC|n 82139478‏
996 ‎‡2  CAOONL|ncf13791440‏
996 ‎‡2  LC|n 88164040‏
996 ‎‡2  RERO|A009679142‏
996 ‎‡2  LC|nb2008008502‏
996 ‎‡2  LC|n 86065035‏
996 ‎‡2  LC|n 2024000871‏
996 ‎‡2  CAOONL|ncf10185512‏
996 ‎‡2  LC|nr2005000765‏
996 ‎‡2  LC|n 85025110‏
996 ‎‡2  LC|no2023049626‏
996 ‎‡2  NUKAT|n 01055347‏
996 ‎‡2  LC|nb2005004810‏
996 ‎‡2  CAOONL|ncf11241663‏
996 ‎‡2  DE633|pe41001347‏
996 ‎‡2  DNB|1147164150‏
996 ‎‡2  RERO|A023584791‏
996 ‎‡2  LC|no2011140919‏
996 ‎‡2  NSK|000178708‏
996 ‎‡2  DNB|137743599‏
996 ‎‡2  RERO|A014053917‏
996 ‎‡2  BNF|12336521‏
996 ‎‡2  NDL|00835693‏
996 ‎‡2  LC|n 2002154077‏
996 ‎‡2  CAOONL|ncf11520703‏
996 ‎‡2  KRNLK|KAC199617793‏
996 ‎‡2  BNF|13475859‏
996 ‎‡2  BIBSYS|3014608‏
996 ‎‡2  SUDOC|198292317‏
996 ‎‡2  BIBSYS|90802532‏
996 ‎‡2  BNF|12505013‏
996 ‎‡2  DNB|1166186962‏
996 ‎‡2  ISNI|0000000070398123‏
996 ‎‡2  NKC|uk20231192542‏
996 ‎‡2  BIBSYS|90500992‏
996 ‎‡2  LC|no2013054155‏
996 ‎‡2  LC|no2008175454‏
996 ‎‡2  ISNI|0000000117545099‏
996 ‎‡2  NII|DA10218792‏
996 ‎‡2  ISNI|0000000043660691‏
996 ‎‡2  ISNI|0000000038206574‏
996 ‎‡2  NII|DA12511845‏
996 ‎‡2  ISNI|0000000050372129‏
996 ‎‡2  CAOONL|ncf10312167‏
996 ‎‡2  LC|no2013002102‏
996 ‎‡2  ISNI|0000000035452788‏
996 ‎‡2  BIBSYS|5069214‏
996 ‎‡2  LIH|LNB:BIY_b_;=B_c_‏
996 ‎‡2  ICCU|CUBV099975‏
996 ‎‡2  NTA|166966053‏
996 ‎‡2  NUKAT|n 2013045482‏
996 ‎‡2  ISNI|0000000455869010‏
996 ‎‡2  NTA|131760874‏
996 ‎‡2  PLWABN|9811797750905606‏
996 ‎‡2  ISNI|0000000115004731‏
996 ‎‡2  NDL|01044525‏
996 ‎‡2  RERO|A006323600‏
996 ‎‡2  LC|no2024091005‏
996 ‎‡2  J9U|987007446657505171‏
996 ‎‡2  DNB|1037596137‏
996 ‎‡2  ISNI|0000000390362234‏
996 ‎‡2  ISNI|0000000084790863‏
996 ‎‡2  RERO|A005754858‏
996 ‎‡2  J9U|987007447040405171‏
996 ‎‡2  LC|nb2011013575‏
996 ‎‡2  DNB|173390145‏
996 ‎‡2  CAOONL|ncf10619090‏
996 ‎‡2  LC|no2023063245‏
996 ‎‡2  CAOONL|ncf11608132‏
996 ‎‡2  J9U|987007274130005171‏
996 ‎‡2  BNF|12323995‏
996 ‎‡2  B2Q|0000680548‏
996 ‎‡2  RERO|A003564757‏
996 ‎‡2  BLBNB|000289827‏
996 ‎‡2  SUDOC|275626083‏
996 ‎‡2  ISNI|0000000384558978‏
996 ‎‡2  BNF|14954742‏
996 ‎‡2  BIBSYS|90541877‏
996 ‎‡2  LC|n 79090657‏
996 ‎‡2  LC|n 95115634‏
996 ‎‡2  PLWABN|9810565974705606‏
996 ‎‡2  BNF|12252140‏
996 ‎‡2  ISNI|0000000121426762‏
996 ‎‡2  LC|n 92052178‏
996 ‎‡2  LC|n 98007191‏
996 ‎‡2  J9U|987007444558605171‏
996 ‎‡2  SUDOC|172640318‏
996 ‎‡2  LC|n 2001014933‏
996 ‎‡2  LC|no2010134597‏
996 ‎‡2  CAOONL|ncf10465690‏
996 ‎‡2  LC|no2019106696‏
996 ‎‡2  LC|n 83149375‏
996 ‎‡2  PLWABN|9813283262805606‏
996 ‎‡2  LC|no2019164287‏
996 ‎‡2  PLWABN|9813924973505606‏
996 ‎‡2  SUDOC|229057799‏
996 ‎‡2  BIBSYS|90089352‏
996 ‎‡2  NUKAT|n 01028599‏
996 ‎‡2  NTA|075273497‏
996 ‎‡2  BIBSYS|90201268‏
996 ‎‡2  ISNI|0000000072524779‏
996 ‎‡2  LC|n 94008534‏
996 ‎‡2  BIBSYS|90076580‏
996 ‎‡2  ISNI|000000042365391X‏
996 ‎‡2  J9U|987007324607205171‏
996 ‎‡2  NTA|244191980‏
996 ‎‡2  LNB|LNC10-000126212‏
996 ‎‡2  LC|no2022112629‏
996 ‎‡2  NKC|xx0015323‏
996 ‎‡2  SUDOC|067203183‏
996 ‎‡2  ISNI|0000000383917166‏
996 ‎‡2  J9U|987007379446105171‏
996 ‎‡2  B2Q|0000271069‏
996 ‎‡2  NUKAT|n 95304202‏
996 ‎‡2  DNB|1175133736‏
996 ‎‡2  CAOONL|ncf10994598‏
996 ‎‡2  LC|no 96015274‏
996 ‎‡2  ISNI|0000000140281757‏
996 ‎‡2  BIBSYS|90180001‏
996 ‎‡2  ISNI|000000003412140X‏
996 ‎‡2  BAV|495_232319‏
996 ‎‡2  BIBSYS|1035022‏
996 ‎‡2  J9U|987007326920605171‏
996 ‎‡2  BNF|17152371‏
996 ‎‡2  LC|no2016118515‏
996 ‎‡2  LC|n 91041249‏
996 ‎‡2  BIBSYS|90774157‏
996 ‎‡2  ISNI|0000000115949655‏
996 ‎‡2  DNB|1158118112‏
996 ‎‡2  ISNI|0000000017866995‏
996 ‎‡2  CAOONL|ncf10162285‏
996 ‎‡2  J9U|987007459411605171‏
996 ‎‡2  SUDOC|032153864‏
996 ‎‡2  LC|n 80091576‏
996 ‎‡2  LC|nb2006005794‏
996 ‎‡2  J9U|987007444473605171‏
996 ‎‡2  BNC|981058611153806706‏
996 ‎‡2  LC|n 79015965‏
996 ‎‡2  J9U|987007605654005171‏
996 ‎‡2  SUDOC|034278370‏
996 ‎‡2  ISNI|0000000384156063‏
996 ‎‡2  NLB|18560084‏
996 ‎‡2  BIBSYS|5062031‏
996 ‎‡2  NUKAT|n 98701644‏
996 ‎‡2  SUDOC|035146567‏
996 ‎‡2  SUDOC|067046436‏
996 ‎‡2  BNE|XX5516321‏
996 ‎‡2  J9U|987007451319205171‏
996 ‎‡2  SUDOC|061440043‏
996 ‎‡2  BIBSYS|6034611‏
996 ‎‡2  LC|n 99801698‏
996 ‎‡2  NII|DA10104636‏
996 ‎‡2  PTBNP|112239‏
996 ‎‡2  LC|n 80068168‏
996 ‎‡2  LC|nb2001087060‏
996 ‎‡2  ISNI|0000000440036526‏
996 ‎‡2  BIBSYS|5067944‏
996 ‎‡2  ISNI|0000000073797023‏
996 ‎‡2  ISNI|0000000033326091‏
996 ‎‡2  NUKAT|n 2022092101‏
996 ‎‡2  CAOONL|ncf10604215‏
996 ‎‡2  SUDOC|147101719‏
996 ‎‡2  DBC|87097968684536‏
996 ‎‡2  DNB|1074315650‏
996 ‎‡2  LC|no2003111795‏
996 ‎‡2  LC|nb2016022516‏
996 ‎‡2  LC|nr 94006089‏
996 ‎‡2  CAOONL|ncf11332966‏
996 ‎‡2  LC|no2015111797‏
996 ‎‡2  SUDOC|193577615‏
996 ‎‡2  NTA|068617224‏
996 ‎‡2  J9U|987007338426105171‏
996 ‎‡2  N6I|vtls000045472‏
996 ‎‡2  VLACC|000036250‏
996 ‎‡2  NSK|000086128‏
996 ‎‡2  PLWABN|9810607796005606‏
996 ‎‡2  CAOONL|ncf10891026‏
996 ‎‡2  NSK|000025580‏
996 ‎‡2  ISNI|0000000047210583‏
996 ‎‡2  BNF|14497201‏
996 ‎‡2  LC|n 97104139‏
996 ‎‡2  LC|n 2014069562‏
996 ‎‡2  LC|nb2006012438‏
996 ‎‡2  NII|DA0017328X‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏